m-PEG7-aldehyde - ≥95% , CAS No.1058691-77-2

CAS: 1058691-77-2 Cat. No.: M596822 Formula: C16H32O8 Peso molecolare: 352.42
Disponibile su ordine
QUALITÀ & PUREZZA ≥95%
Synonyms
4,7,10,13,16,19,22-Heptaoxatricosanal|m-PEG6-CH2CH2CHO
Storage
Protected from light,Store at -20°C,Argon charged
Shipped In
Ice chest + Ice pads
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
100mg
M596822-100mg
Su ordinazione · 8–12 settimane

85,82€

129,21€
Salva 43,39 € (33.58%)
500mg
M596822-500mg
Su ordinazione · 8–12 settimane

321,84€

483,24€
Salva 161,40 € (33.40%)
Enter a quantity for the sizes you want to add.

Panoramica

m-PEG7-aldehyde is a PEG derivative containing an aldehyde group. Aldehyde is reactive to hydrazide and aminooxy groups which are commonly used in biomolecular probes for labeling and crosslinking carbonyls (oxidized carbohydrates). The hydrophilic PEG spacer increases solubility in aqueous media.

Specifiche

Sinonimi
4,7,10,13,16,19,22-Heptaoxatricosanal | m-PEG6-CH2CH2CHO
Specifiche e purezza
≥95%
Meccanismi biochimici e fisiologici
m-PEG6-CH2CH2CHO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG6-CH2CH2CHO is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Condizioni di conservazione di stoccaggio
Protected from light,Store at -20°C,Argon charged
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Purezza
≥95%
Nomi e identificatori
SMILES
COCCOCCOCCOCCOCCOCCOCCC=O
IUPAC Name
3-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanal
InChIKey
OFRPYQRIPDCCAA-UHFFFAOYSA-N
InChI
1S/C16H32O8/c1-18-5-6-20-9-10-22-13-14-24-16-15-23-12-11-21-8-7-19-4-2-3-17/h3H,2,4-16H2,1H3
Isomeri SMILES
COCCOCCOCCOCCOCCOCCOCCC=O
Peso molecolare
352.42

Dati avanzati

Struttura 3D
Modello di struttura chimica interattiva





Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Proprietà chimiche e fisiche
SolubilitàSolubility in Water, DMSO, DCM, DMF
SensibilitàMoisture sensitive;Light sensitive
Peso molecolare352.42
XLogP3-1.400
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count21
Exact Mass352.21 Da
Monoisotopic Mass352.21 Da
Topological Polar Surface Area81.700 Ų
Heavy Atom Count24
Formal Charge0
Complexity240.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

No vendor-validated application protocols are provided for this SKU. The following general procedures (literature-based) can serve as starting points and should be optimized per system.

  • Oxime ligation to an aminooxy-labeled peptide/protein:

    1. Dissolve m-PEG7-aldehyde at 10–50 mM in DMSO (stock). Prepare 100 mM sodium acetate buffer, pH 5.0.
    2. Mix peptide (50–200 µM) in buffer with 5–10% DMSO; add aldehyde to 5–20 equiv.
    3. Add aniline catalyst to 50 mM (optional). Incubate at rt for 2–6 h.
    4. Analyze by LC-MS/SDS-PAGE. Purify by RP-HPLC or desalting.
  • Reductive amination onto an amine-terminated surface (silica/polymer):

    1. Pre-wet surface in MeOH, then equilibrate in 100 mM phosphate buffer pH 7.0 with 20% EtOH.
    2. Add m-PEG7-aldehyde (5–50 mM). Incubate 1 h at rt with gentle agitation.
    3. Add NaBH3CN to 20 mM and continue 4–16 h.
    4. Rinse thoroughly with buffer, then water and alcohol. Cure/dry as appropriate.
  • Hydrazide coupling (biopolymer/carbohydrate):

    1. Prepare hydrazide partner in 100 mM acetate buffer, pH 5.0.
    2. Add aldehyde (2–10 equiv) and optional aniline (50 mM). Incubate 2–12 h at rt.
    3. Optionally reduce with NaBH3CN to stabilize. Purify accordingly.

Note: These are general guidelines. Validate on small scale and consult the SDS and CoA for handling constraints.

Biological Roles

This item is a synthetic polymeric reagent rather than a native biomolecule; it does not possess intrinsic biological activity. However, short methoxy-PEG aldehydes are widely used in biological research as inert, hydrophilic tethers and surface modifiers.

General, literature-based roles and effects:

  • Protein resistance and stealthing: PEG chains reduce nonspecific protein adsorption and can diminish recognition by biomolecular surfaces due to steric repulsion and water structuring around the ether oxygens.
  • Bioconjugation handle: The aldehyde reacts chemoselectively with aminooxy/hydrazide functionalities on biomolecules or with primary amines via reductive amination, enabling labeling, immobilization, and PEGylation strategies.
  • Spacer/linker: Seven EO units provide a short, flexible spacer (~3–4 nm fully extended; significantly shorter in aqueous random coil), separating functional payloads from biomolecular surfaces to improve binding or reduce steric hindrance (approximate literature description; exact length depends on conformation and hydration).
  • Surface engineering: PEGylated surfaces reduce cell adhesion and fouling in in vitro assays and microfluidics, improving signal-to-noise for biosensing and cell-based studies.

No medical or clinical claims are made. Use is limited to research and laboratory applications as indicated by the Research Use Note. For application-specific biological compatibility (e.g., with live cells), empirical testing is recommended.

Buffer Applications

This product is not a buffering agent and is not typically used to prepare pH-stable buffer systems.

Practical guidance related to buffers for its intended reactions (general/literature):

  • Oxime/hydrazone ligation: Use sodium acetate buffer, pH 4.5–5.5 (50–200 mM). Optional aniline catalyst (10–100 mM) greatly accelerates kinetics, especially at neutral pH.
  • Reductive amination: Use phosphate buffer, pH 6.0–7.5 (50–200 mM). Include NaBH3CN (10–50 mM) or picoline borane; avoid high primary amine buffer components (e.g., Tris, glycine) that compete with the target amine.
  • Protein compatibility: Maintain ionic strength (50–150 mM NaCl) and add 5–20% DMSO/EtOH only as needed to solubilize m-PEG7-aldehyde without denaturing proteins.

Recipe hints (general):

  • Degas buffers and filter (0.22 µm). Adjust pH at the working temperature. For hydrazone/oxime ligations at neutral pH, include aniline and consider longer reaction times or elevated temperature (up to 37 °C) for robust substrates.
Green Alternatives

Greener choices can be made at the level of solvent, catalyst, and polymer platform. The aldehyde functionality itself is efficient and compatible with aqueous media, supporting greener processing.

  • Solvent selection (greener options):

    • Prefer water or aqueous buffers for oxime/hydrazone ligations; add minimal DMSO/EtOH as co-solvents instead of DMF/MeCN when feasible.
    • Use ethanol or isopropanol for cleaning and precipitation steps in place of chlorinated solvents.
  • Catalysis:

    • Aniline catalysis enables faster ligation at lower aldehyde excess and milder temperatures, reducing energy use. Consider recyclable aniline sulfonic acids or solid-supported catalysts to simplify removal.
  • Polymer platform alternatives (application-dependent):

    • Polyglycerol (hyperbranched) or linear polyglycerol: similar hydrophilicity, improved oxidative stability; fully polyether, derived from glycerol.
    • Polysarcosine (poly(N-methylglycine)): non-ionic, protein-repellent, biodegradable tendencies; avoids ethylene oxide monomer origin.
    • Oligo(ethylene glycol) (OEG) vs higher MW PEG: choose the minimal chain length (here, 7 units) that achieves performance to reduce mass and persistence.

Small comparison (general, literature):

  • Water-based oxime ligation vs DMF-based reductive amination:
    • Pros (water/oxime): minimal organic solvent, mild pH 4.5–5.5, no cyanoborohydride; Cons: oxime/hydrazone stability can be lower unless reduced.
    • Pros (reductive amination): forms robust C–N bonds; Cons: uses reducing salts (waste), often requires organic co-solvent.

Note: Select alternatives based on substrate stability and end-use. Always validate performance against your application’s specifications.

Pharmaceutical Uses

No pharmacopeial status, excipient designation, or clinical use is specified for this item; refer to CoA/Spec Sheet. The following describes research/formulation roles in a non-clinical context (literature/general):

  • PEGylation reagent in formulation development: Used to explore how short PEG spacers modulate solubility, aggregation, and surface interactions of candidate biomolecules, peptides, or nanoparticles.
  • Surface passivation: Modification of device and container-contact surfaces (syringes, microfluidic chips, assay plates) to reduce adsorption of actives during analytical development.
  • Prototyping linkers: Aldehyde end-group allows rapid assembly of PEG-linked conjugates (e.g., drug-linker mimics) for pre-formulation screening and analytical method development.
  • Controlled hydrophilicity: Incorporation into macromolecules or dendrimers to tune aqueous compatibility and viscosity of research formulations.

Important: This product is supplied for research use only and is not intended for human or veterinary use, clinical diagnostics, or as an excipient in commercial drug products.

Physical Properties

Item-specific physico-chemical specifications have not been provided for this SKU.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight (Mn) and polydispersity: Not specified for this item; refer to CoA/Spec Sheet.
  • Density, refractive index, pKa/logP, UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.

General/literature characteristics for short mPEG-aldehydes (context only):

  • Physical state: Low–moderate MW mPEG oligomers often present as viscous oils, waxy solids, or glassy materials depending on exact Mn and dispersity.
  • Solubility: Highly soluble/miscible in water and polar organics (MeOH, EtOH, acetonitrile, acetone, DMSO, DMF); limited solubility in nonpolar hydrocarbons (hexane, heptane). PEG chains promote hydrophilicity and water miscibility.
  • Thermal behavior: PEG oligomers typically show broad softening rather than a sharp melting point; glass transition around −50 to −30 °C and crystalline/melting features depend on chain length (literature, varies with Mn and dispersity).
  • Vapor pressure: Negligible; nonvolatile under ambient conditions.

Notes for users:

  • For precise solubility, water/volatile content, and any stabilizers, consult the lot-specific CoA. Aldehyde content/assay may be reported as %CHO or by hydroxylamine titration/NMR on supplier documents.
Quality and Grades
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Considerations specific to m-PEG7-aldehyde quality (general guidance for evaluation):

  • Aldehyde functionality: Effective aldehyde content is critical for conjugation efficiency. Suppliers may report % reactive CHO by hydroxylamine assay or NMR integration. Verify by a small-scale test ligation (e.g., with aminooxy-biotin) if critical.
  • Oligomer distribution: For defined mPEG7, low dispersity (ideally discrete heptamer) is desirable. MALDI-TOF or ESI-MS can confirm distribution and Mn.
  • Residual impurities: Check CoA for residual solvents (e.g., toluene, DMF), metals (from synthesis catalysts), and water content (Karl Fischer). For bioconjugation, low water and low amine contaminants are important.
  • UV background: PEG has minimal UV absorbance above 220 nm, but aldehydes may show weak n→π* around 280–300 nm; for HPLC applications, ensure the grade supports low baseline drift if relevant (HPLC grade, if offered).
  • Stabilization: Product is shipped argon charged; no stabilizer is listed for this item. If a stabilizer is present in a particular lot, it should be declared on the CoA/Spec Sheet.

Recommendation: For protein or surface conjugation workflows, request CoA metrics relevant to your use (aldehyde content, Mn/distribution, water, residual solvent) and perform incoming QC on a representative aliquot.

Reaction and Applications

m-PEG7-aldehyde is a versatile hydrophilic linker for covalent conjugation and materials functionalization. Key reaction manifolds (literature/general):

  • Oxime formation (aminooxy groups):

    • Mechanism: Nucleophilic addition of aminooxy to aldehyde, dehydration to oxime; catalyzed by anilinium catalysts.
    • Typical conditions: pH 4.5–5.5 (acetate buffer), rt, 1–12 h. Aniline or p-phenylenediamine (10–100 mM) accelerates ligation at neutral sites on proteins and surfaces.
    • Applications: Site-selective protein/peptide PEGylation (N-termini transamination → aminooxy; periodate-oxidized glycans), carbohydrate conjugation, hydrogel crosslinking.
  • Hydrazone formation (hydrazides):

    • Conditions: pH 4.5–6.0, rt to 37 °C; aniline catalysis optional. Product may be converted to more stable linkages via reduction (NaBH3CN or picoline borane).
  • Reductive amination (primary amines):

    • Conditions: pH 6.0–7.5 (phosphate), 10–50 mM NaBH3CN or NaBH(OAc)3, rt to 37 °C, 2–24 h. Forms stable secondary amines; widely used for N-terminal PEGylation and resin/surface functionalization.
  • Acetal/hemiacetal chemistry:

    • Protection or polymer modification under acid catalysis with diols; generally avoided in bioconjugation.
  • Materials science:

    • Imparts hydrophilicity and protein-resistance to surfaces (self-assembled monolayers, nanoparticles, microfluidic channels).
    • Serves as a spacer to reduce steric hindrance and enhance aqueous dispersibility in dyes, catalysts, and sensors.

Practical tips:

  • Use freshly prepared aldehyde solutions; store aliquots under inert gas at −20 °C.
  • Control moisture and pH; include catalysts for efficient ligation at mild conditions.
  • Verify conjugation by MALDI, LC-MS (small molecules), SDS-PAGE shift (proteins), or XPS/contact angle (surfaces).
Reaction Conditions

General, literature-based conditions for common ligations with m-PEG7-aldehyde:

  • Oxime ligation (aminooxy partner):

    • Buffer: 50–200 mM sodium acetate, pH 4.5–5.5.
    • Catalyst: Aniline or p-phenylenediamine 10–100 mM (optional but accelerative), or anthranilic acid derivatives for near-neutral pH.
    • Concentration: 0.1–10 mM aldehyde; stoichiometry 1.2–5.0 equiv vs aminooxy depending on substrate.
    • Temperature/time: rt, 1–12 h (37 °C for difficult substrates). Typical conversions 70–>95% (literature) depending on sterics and hydration.
  • Hydrazone formation (hydrazide partner):

    • Buffer: pH 4.5–6.0 (acetate or citrate), optional aniline.
    • Conditions: Similar to oxime; hydrazones may be reduced post-coupling for stability.
  • Reductive amination (primary amine partner):

    • Buffer: 50–200 mM phosphate, pH 6.0–7.5; avoid primary amine buffers (Tris, glycine).
    • Reductant: NaBH3CN (10–50 mM) or picoline borane (safer), added after imine formation (15–60 min pre-equilibration).
    • Solvent: Water with 5–30% DMSO/EtOH to aid solubility.
    • Temperature/time: rt to 37 °C, 2–24 h. Typical isolated yields for small molecules 60–90% (literature), higher in excess aldehyde.

General tips:

  • Remove dissolved oxygen (argon sparge) to minimize aldehyde oxidation.
  • Use molecular sieves (3Å) in organic media to drive imine formation.
  • Monitor by LC-MS, NMR, or UV (derivatized partners) and quench with NaBH4/NaBH3CN as needed to lock linkages.
Safety and Handling
  • GHS classification, signal word, pictograms, and H-statements: Not specified for this item; refer to SDS.
  • Primary hazards (general for PEG-aldehydes):
    • Aldehydes are electrophilic and can be irritants to skin, eyes, and respiratory tract; avoid inhalation of aerosols and contact.
    • Polyether chains are generally of low acute toxicity but can enhance dermal/ocular penetration of the aldehyde end-group.
  • PPE: Use lab coat, safety glasses, and chemical-resistant gloves (e.g., nitrile). Handle in a fume hood when preparing concentrated solutions or during activation steps.
  • Handling guidance:
    • Keep under inert atmosphere as provided (argon charged) to minimize oxidation of the aldehyde to the corresponding acid/hydrate.
    • Minimize exposure to moisture; aldehydes form hydrates and imines with adventitious amines.
    • Avoid strong oxidizers, strong bases (which can promote aldol/self-condensation if reactive alpha positions exist in the linker), and reducing agents unless performing reductive amination intentionally.
  • First aid (general):
    • Skin/eye contact: Rinse with water for at least 15 minutes. Remove contaminated clothing. Seek medical attention if irritation persists.
    • Inhalation: Move to fresh air; seek medical attention if symptoms occur.
    • Ingestion: Rinse mouth; do not induce vomiting; obtain medical attention.
  • Spill/cleanup: Absorb with inert material, collect for disposal. Wash area with water/detergent. Prevent release to drains until assessed.
  • Fire safety: PEGs are combustible. Use CO2, dry chemical, or foam. Thermal decomposition may release CO/CO2; aldehydes can form irritating vapors on heating.
  • Always defer to the product SDS for authoritative safety information.
Solvent Selection

General solvent behavior for short-chain mPEG-aldehydes (literature-based):

  • Polarity/miscibility:
    • Highly miscible with water and polar organics: DMSO, DMF, methanol, ethanol, acetonitrile, acetone.
    • Partially soluble to insoluble in nonpolar solvents: hexane, heptane; better solubility in moderately polar ethers/esters (THF, EtOAc).
  • Practical choices by application:
    • Protein/biomolecule conjugation: Aqueous buffers (acetate, phosphate) with 5–30% co-solvent (DMSO, DMF) to aid dissolution while maintaining biomolecule stability.
    • Surface and polymer modification: Neat DMF/DMSO, acetonitrile, or aqueous-organic mixtures depending on substrate compatibility.
    • Small-molecule synthesis: Anhydrous MeOH, EtOH, THF, MeCN, DCM/MeOH mixes for derivatization; keep water content low for imine/oxime formation unless hydration is desired to moderate rate.
  • Tips:
    • Degas and dry solvents to limit aldehyde oxidation/hydration. Molecular sieves (3Å) in MeCN/MeOH can improve imine/oxime yields.
    • For protein N-terminal PEGylation, acetate buffer pH 4.5–5.5 with aniline catalyst (10–50 mM) is common to accelerate oxime formation while preserving protein structure.

Comparison (general):

  • DMSO vs DMF: DMSO offers broader biocompatibility and lower volatility; DMF provides lower viscosity and faster mass transfer but may denature proteins.
  • MeOH/EtOH: Green, volatile, and easy to remove; may promote acetal formation with aldehydes under acid—control pH and time.
Storage and Reconstitution

Item-specific storage/shipping (from Product Data):

  • Storage Conditions: Protected from light, Store at −20 °C, Argon charged.
  • Shipped In: Ice chest + Ice pads.

General best practices for aldehyde-terminated PEG reagents:

  • Packaging: Keep container tightly closed under inert gas (argon) with desiccant. Minimize headspace and moisture ingress.
  • Aliquoting: Upon first opening, warm to room temperature in a desiccator, then immediately prepare small aliquots under dry inert atmosphere to avoid repeated freeze–thaw and moisture uptake.
  • Reconstitution:
    • For organic stock: Dissolve in anhydrous DMSO, DMF, MeCN, or MeOH to 10–100 mM. Store aliquots at −20 °C, argon headspace.
    • For aqueous use: Prepare immediately before use in degassed buffer at the required pH. Avoid prolonged storage in water due to hydrate formation and potential oxidation to acids.
  • Stability (general/literature): Aldehydes can slowly oxidize or hydrate; stability improves under dry, oxygen-free, light-protected conditions at −20 °C. Avoid strong acids/bases and elevated temperatures.
  • Thawing/handling: Allow vials to equilibrate to room temperature before opening to prevent moisture condensation. Reseal promptly and re-charge headspace with inert gas if available.

For lot-specific shelf life, residual solvent/water limits, and any stabilizers: Not specified for this item; refer to CoA/Spec Sheet.

Structure and Identity

m-PEG7-aldehyde is a methoxy-terminated oligo(ethylene glycol) bearing an aldehyde at the opposite terminus, enabling chemoselective conjugation to nucleophiles (amines, hydrazides, aminooxy).

  • Item-specific identifiers (from Product Data):

    • SKU: M596822
    • Product Name: m-PEG7-aldehyde
    • CAS: 1058691-77-2
    • CID: 102514883
    • InChIKey: 256740 (as provided)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general/literature description):

    • Backbone: A linear polyether chain of seven ethylene glycol repeat units [–(CH2–CH2–O)7–].
    • Termini: One end is methoxy-capped (–O–CH3); the other end bears an aldehyde (–CHO) functionality via a short linker or directly on the terminal carbon (supplier-dependent; see CoA for exact linker length).
    • Functional groups: Ether oxygens (H-bond acceptors), one aldehyde carbonyl (electrophilic), terminal methoxy (non-reactive cap).
    • Stereochemistry: None (achiral, flexible chain).
  • 2D structure in words (general): A flexible, linear PEG chain with alternating –CH2–CH2– units separated by oxygens, terminated on one end by a methoxy group and on the other by an aldehyde group suitable for oxime/hydrazone formation or reductive amination.

Synthetic Utility

As a bifunctional reagent (reactive aldehyde + inert methoxy cap), m-PEG7-aldehyde is a modular hydrophilic spacer for organic synthesis and materials modification.

Key transformations (general/literature):

  • Imine chemistry: Rapid formation of imines with primary amines; subsequent reduction affords secondary amines bearing a PEG7 spacer (robust C–N bond formation under mild conditions).
  • Oxime/hydrazone ligation: Chemoselective coupling to aminooxy or hydrazide partners in water, enabling late-stage introduction of PEGylation with minimal protecting-group manipulation.
  • Carbonyl interconversions: Oxidation to the corresponding acid, reduction to alcohol (NaBH4) to give m-PEG7-CH2OH derivatives, or Wittig/olefination to install vinyl-PEG constructs.
  • Acetal formation: Temporary protection as acetals to enable multistep sequences on the PEG chain without side reactions of the carbonyl.
  • Surface coupling: Aldehyde-enabled grafting to amine-terminated surfaces (silica, polymer films, nanoparticles) via imine formation and in situ reduction, imparting hydrophilicity and antifouling character.

Retrosynthetic value:

  • Provides a defined-length, non-ionic spacer to separate functional motifs, enhance water solubility, and modulate pharmacophore exposure in probe and sensor design.

Analytical characterization:

  • 1H/13C NMR (imine/oxime formation shifts), IR (C=O ~1720 cm−1; imine ~1640–1660 cm−1), MS (MALDI/ESI), and HPLC/SEC for purity and dispersity checks.
Target Specificity

This product is not a biological targeting reagent (e.g., antibody, ligand) and has no defined target specificity.

  • Antigen/epitope, clone, isotype, species reactivity: Not applicable.
  • Any such attributes would be listed in the Product Data or CoA; none are provided for this item.

Use-case note: Specificity in applications arises from the partner functionality (e.g., aminooxy on a particular biomolecule, amine-terminated surface), not from intrinsic biological recognition by m-PEG7-aldehyde.

Domande frequenti

What is the purity of this product?
This product is supplied at ≥95% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C, protected from light, under argon. It is supplied under an argon blanket; reseal under inert gas after each use.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 1058691-77-2, the molecular formula is C16H32O8, and the molecular weight is 352.42 g/mol. InChIKey OFRPYQRIPDCCAA-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.